Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1984 Oct 1;160(4):1043-53.
doi: 10.1084/jem.160.4.1043.

Stimulation of human endothelial cell prostacyclin synthesis by select leukotrienes

Stimulation of human endothelial cell prostacyclin synthesis by select leukotrienes

L G Pologe et al. J Exp Med. .

Abstract

Cultured endothelial cells from human umbilical cord labeled with [3H]20:4 release radiolabel when exposed to leukotrienes C or D (LTC or LTD). The major radiolabeled 20:4 metabolite recovered in the culture medium was prostacyclin. Both leukotrienes produced a dose-dependent synthesis of prostacyclin, with a maximal response at 10(-7) M leukotriene. LTC promoted a twofold greater response than did LTD at all concentrations tested (10(-9) to 10(-7) M). In contrast, no release of radiolabel above basal levels was evident with a challenge of LTE or LTB at the same concentrations. Endothelial cells metabolize approximately 40-50% of exogenously supplied LTC to LTD and LTE in 60 min. Levels of alpha-glutamyltranspeptidase (gamma-GTPase), the ectoenzyme reported to convert LTC or LTD, were detected in intact endothelial cells with the chromogenic substrate L-gamma-glutamyl-p-nitroanilide at levels sufficient to account for the observed rate of LTC metabolism. High concentrations of the gamma-GTPase inhibitors, glutathione and AT-125, blocked the metabolism of LTC by endothelium. These results suggest that degradation of leukotrienes by endothelium may be one mechanism for inactivation of these lipid mediators.

PubMed Disclaimer

Similar articles

Cited by

References

    1. J Clin Invest. 1973 Nov;52(11):2757-64 - PubMed
    1. J Biol Chem. 1974 Dec 10;249(23):7593-602 - PubMed
    1. Proc Natl Acad Sci U S A. 1979 Jan;76(1):268-72 - PubMed
    1. Br J Pharmacol. 1979 Mar;65(3):517-24 - PubMed
    1. Biochem Biophys Res Commun. 1979 Dec 28;91(4):1266-72 - PubMed

Publication types